PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 490 Folge(n) erschienen. Alle 4 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 8 days 18 minutes

subscribe
share






An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care


An In-Depth Look at the EMA Guidelines for Biosimilars From Creation to Care


share








 2014-09-09  17m
 
 

Biologic Treatment Decisions in RA: Considering Mechanisms, Evidence, and Patients


Go online to www.peervoice.com/h/pvr157 to view the entire programme with slides.


share








 2014-08-28  17m
 
 

Why is There a Window of Opportunity? The Immunopathological Basis of MS


Why is There a Window of Opportunity? The Immunopathological Basis of MS


share








 2014-08-18  17m
 
 

Strategic Use of ICS/LABA Combination Therapy in Asthma


Strategic Use of ICS/LABA Combination Therapy in Asthma


share








 2014-08-14  13m
 
 

Expert Insights in Psychiatry: Bipolar Disorder


Expert Insights in Psychiatry: Bipolar Disorder


share








 2014-08-06  7m
 
 

Viral Cure: A Shift in Thinking


Viral Cure: A Shift in Thinking


share








 2014-07-02  23m
 
 

Antimicrobial Resistant Infections in the Acute Care Setting: Prevalence, Consequences, and Prevention Strategies


Go online to www.peervoice.com/h/pve50 to view the entire programme with slides.


share








 2014-06-27  28m
 
 

Originators, Generics, and Biosimilars: How They Are Assessed


Originators, Generics, and Biosimilars: How They Are Assessed


share








 2014-06-12  16m
 
 

Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?


Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?


share








 1970-01-01  18m
 
 

State of the Science in CKD: New Treatment, New Outcomes


State of the Science in CKD: New Treatment, New Outcomes


share








 1970-01-01  18m